МЕТИЦИЛЛИНГА ЧИДАМЛИ STAPHYLOCOCCUS AUREUS ШТАММЛАРИНИНГ МОЛЕКУЛЯР-ГЕНЕТИК ТАҲЛИЛИ
Kalit so‘zlar:
Staphylococcus aureus, MRSA, mecA, ПЗР, молекуляр-генетик таҳлилAbstrak
Тадқиқотда Республика шошилинч тиббий ёрдам илмий марказида 2026 йил март ойида стационар даволанган беморлардан олинган 252 та клиник намуна асосида Staphylococcus aureus штаммларининг молекуляр-генетик таҳлили баён этилган. Реал вақт режимида полимер занжирли реакция усули орқали mecA гени аниқланиб, 164 та (65,1%) изолят метициллинга чидамли Staphylococcus aureus сифатида тасдиқланди. Метициллинга чидамли Staphylococcus aureus штаммларининг ДНК ўлчамлари гел-электрофорез усулида 200 бп (base pare)дан иборатлиги аниқланди
##plugins.themes.default.displayStats.downloads##
Havolalar
1. Ambade, S. S., Gupta, V. K., Bhole, R. P., Khedekar, P. B., & Chikhale, R. V. (2023). A review on five and six-membered heterocyclic compounds targeting the penicillin-binding protein 2 (PBP2A) of methicillin-resistant Staphylococcus aureus (MRSA). Molecules, 28(20), 7008.
2. Gurung, R. R., Maharjan, P., & Chhetri, G. G. (2020). Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Future science OA, 6(4), FSO464.
3. Chen, H., Yin, Y., van Dorp, L., Shaw, L. P., Gao, H., Acman, M., ... & Balloux, F. (2021). Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China. Genome medicine, 13(1), 171.
4. Khairullah, A. R., Rehman, S., Sudjarwo, S. A., Effendi, M. H., Ramandinianto, S. C., Gololodo, M. A., ... & Kurniawati, D. A. (2022). Detection of mecA gene and methicillin-resistant Staphylococcus aureus (MRSA) isolated from milk and risk factors from farms in Probolinggo, Indonesia. F1000Research, 11, 722.
5. Nataraj, B. H., & Mallappa, R. H. (2021). Antibiotic resistance crisis: an update on antagonistic interactions between probiotics and methicillin-resistant Staphylococcus aureus (MRSA). Current microbiology, 78(6), 2194-2211.
6. Verma, R., Verma, S. K., Rakesh, K. P., Girish, Y. R., Ashrafizadeh, M., Kumar, K. S. S., & Rangappa, K. S. (2021). Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation. European journal of medicinal chemistry, 212, 113134.
7. Nikolic, I., Aleksic Sabo, V., Gavric, D., & Knezevic, P. (2024). Anti-Staphylococcus aureus activity of volatile phytochemicals and their combinations with conventional antibiotics against methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) strains. Antibiotics, 13(11), 1030.
8. Nandhini, P., Kumar, P., Mickymaray, S., Alothaim, A. S., Somasundaram, J., & Rajan, M. (2022). Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) treatment: a review. Antibiotics, 11(5), 606.
9. Abebe, A. A., & Birhanu, A. G. (2023). Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat. Infection and drug resistance, 7641-7662.
10. Alghamdi, B. A., Al-Johani, I., Al-Shamrani, J. M., Alshamrani, H. M., Al-Otaibi, B. G., Almazmomi, K., & Yusof, N. Y. (2023). Antimicrobial resistance in methicillin-resistant Staphylococcus aureus. Saudi journal of biological sciences, 30(4), 103604.



















